GO
Loading...

Analyst Interviews

Future of restaurant chains   Wed, 9 Jul '14 | 10:46 AM ET
Future of restaurant chains

Discussing the state of the restaurant industry and consumer spending, with Nick Setyan, Wedbush Securities senior equity analyst.

Big opportunity to own momentums: Analyst   Wed, 9 Jul '14 | 10:16 AM ET
Big opportunity to own momentums: Analyst

Gene Munster, Piper Jaffray senior research analyst, looks at some high profile momentum stocks that could be in trouble, and explains why investors need to own quality tech stocks before the holidays.

Analyst says Tesla demand growing   Tue, 8 Jul '14 | 5:15 PM ET
Analyst says Tesla demand growing

Tesla faces a trademark lawsuit from a Chinese businessman who demands the electric car maker stops sales and marketing activities in the country. Colin Rusch, Northland Capital Markets senior research analyst, provides perspective.

Analyst: Why you should own Yahoo   Mon, 30 Jun '14 | 12:08 PM ET
Analyst: Why you should own Yahoo

Discussing the potential moves in Yahoo shares as Alibaba's IPO approaches, with Gene Munster, Piper Jaffray analyst. FMHR trader Josh Brown says Yahoo has not created value in a long time.

Analyst's painful Intel upgrade   Fri, 27 Jun '14 | 12:48 PM ET
Analyst's painful Intel upgrade

Sanford Bernstein analyst Stacy Rasgon admits he missed the trade on Intel, and is "painfully" upgrading the chip maker to market perform.

Best time to buy Celgene, Vertex & more   Fri, 27 Jun '14 | 12:17 PM ET
Best time to buy Celgene, Vertex & more

The biotech ETF soared 67 percent in 2013, but has since been bumpy. Discussing winning and losing stocks in the industry, with Mark Schoenebaum, ISI pharma/biotech analyst.

Where Nike is scoring   Fri, 27 Jun '14 | 9:02 AM ET
Where Nike is scoring

Discussing how Nike is growing their running sector and how much the World Cup is impacting sales, with Paul Swinand, Morningstar equity analyst.

Analyst positive on GoPro potential   Thu, 26 Jun '14 | 5:17 PM ET
Analyst positive on GoPro potential

Discussing sales expectations for GoPro for the rest of the year and beyond, and whether the fad will last, with Michael Pachter, Wedbush Securities analyst.

Realties of Aereo ruling   Wed, 25 Jun '14 | 10:14 AM ET
Realties of Aereo ruling

David Bank, RBC Capital Markets, weighs in on the Aereo decision. Bank says it's much more positive news for the pure play smaller broadcasters, than it is for the larger broadcasters. CNBC's David Faber provides insight.

Analyst says 'bankruptcy odds climbing' for RadioShack

Discussing the likelihood of bankruptcy for RadioShack, with Scott Tilghman, B.Riley senior retail analyst. He outlines two fundamental problems at the company: it hasn't evolved with the times, and traffic.

Airline ticket prices surge 97% in May   Tue, 24 Jun '14 | 2:26 PM ET
Airline ticket prices surge 97% in May

Joseph DeNardi, Stifel Nicolaus airlines analyst, says some airlines are more effective at generating ancillaries than other airline companies. His top stock pick is Delta.

What could get Darden cooking   Fri, 20 Jun '14 | 2:21 PM ET
What could get Darden cooking

Sales at Olive Garden continue to slow. Discussing the health of Darden Restaurant traffic, with Bob Derrington, Wunderlich Securities senior analyst.

Investor activism distracting Darden: Analyst

Discussing what's behind Darden's disappointing earnings and lackluster sales, with Rachael Rothman, Susquehanna Financial Group analyst.

Summer beverage stock plays   Thu, 19 Jun '14 | 2:51 PM ET

Discussing the best trades in the beverage industry right now, with Caroline Levy, CLSA beverage analyst.

Apple's ecosystem strategy   Tue, 3 Jun '14 | 10:16 AM ET
Apple's ecosystem strategy

Walter Piecyk, BTIG wireless research analyst, shares his thoughts on WWDC and explains which competitors will be impacted by Apple's software announcements.

Analyst says Beats deal 'low risk'   Thu, 29 May '14 | 12:17 PM ET
Analyst says Beats deal 'low risk'

Katy Huberty, Morgan Stanley analyst, discusses the potential value in Apple's acquisition of Beats Electronics and shares her thoughts on what to expect from the next iPhone and iWatch.

Apple all about option value: Pro   Thu, 29 May '14 | 10:04 AM ET
Apple all about option value: Pro

Toni Sacconaghi, Sanford C. Bernstein senior research analyst, discusses what the Beats deal means for Apple and if this was the best decision for the tech giant to invest its capital.

Starwood's overseas strategy   Tue, 27 May '14 | 10:06 AM ET
Starwood's overseas strategy

Discussing if big U.S. hotel chains will attempt to domicile overseas to avoid paying U.S. taxes, with Patrick Scholes, SunTrust.

Hollywood's Super Bowl   Fri, 23 May '14 | 3:26 PM ET
Hollywood's Super Bowl

Memorial Day is the traditional kickoff of the summer movie season. Paul Dergarabedian, Rentrak, reveals which blockbusters will clean up at the box office this weekend.

AER, ARO, ANF: Who will go under?   Fri, 23 May '14 | 10:01 AM ET
AER, ARO, ANF: Who will go under?

Adrienne Tennant, Janney Montgomery Scott specialty apparel analyst, discusses Gap's difficult quarter, and the state of the retail sector.

Big Facebook bull   Thu, 22 May '14 | 12:41 PM ET
Big Facebook bull

RBC Capital Markets managing director, Mark Mahaney is one of the most bullish Facebook analysts on the Street. Mahaney says the social media company has two very identifiable revenue opportunities coming out.

Analyst bullish on General Motors   Wed, 21 May '14 | 1:04 PM ET
Analyst bullish on General Motors

Discussing the recall mess at General Motors, and what's to come, with Efraim Levy, S&P Capital IQ Equity Research.

No impact to General Motors sales: Analyst   Tue, 20 May '14 | 2:03 PM ET
No impact to General Motors sales: Analyst

Discussing whether General Motors is seeing any impact to its sales from the recall crisis, with Chris Malone, Fidelum Partners managing partners; Dave Whiston, Morningstar senior equity analyst; and CNBC's Phil LeBeau.

Pfizer deal 'wounded,' not dead: Analyst   Mon, 19 May '14 | 12:15 PM ET
Pfizer deal 'wounded,' not dead: Analyst

AstraZeneca told Pfizer its final offer isn't good enough. Mark Schoenebaum, ISI Group biotech & pharma analyst, provides insight to the potential deal.

How not to fear biotech   Thu, 15 May '14 | 1:24 PM ET
How not to fear biotech

Discussing hot picks in the biotech space, with Matthew Roden, UBS executive director.

GM not taking chances: Analyst   Thu, 15 May '14 | 1:18 PM ET
GM not taking chances: Analyst

Efraim Levy, S&P Capital IQ senior auto analyst, thinks maybe General Motors is pulling ahead recall news earlier.

Dark horse retail picks   Wed, 14 May '14 | 3:27 PM ET
Dark horse retail picks

Eric Beder, Brean Capital retail analyst, and Liz Dunn, Macquarie Capital senior retail analyst, discuss the beaten-down retail sector and provide their top retail plays right now.

Mike Mayo's #1 bank pick   Tue, 13 May '14 | 5:30 PM ET
Mike Mayo's #1 bank pick

Discussing regulatory pressure on the banks, and what his top pick is, with Mike Mayo, CLSA bank analyst.

Analyst rates IBM a buy   Mon, 12 May '14 | 2:44 PM ET
Analyst rates IBM a buy

Discussing IBM's transition to the cloud, and the health of its stock, with Brian White, Cantor Fitzgerald, and Peter Misek, Jefferies & Co.

5 Reasons to own Twitter   Mon, 12 May '14 | 12:51 PM ET
5 Reasons to own Twitter

Why it's the right time to buy Twitter, with Bob Peck, SunTrust Robinson internet analyst.

Contact Analyst Interviews

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

CEO Interviews